Health In Tech Announces Voluntary Extension of Lock-Up Period
STUART, Fla., Dec. 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology,...
Staff
Catalyzing Change in Specialty Care: DaVita Shares Vision for Technology Transformation
NORTHAMPTON, MA / ACCESS Newswire / December 2, 2025 / Approximately 129 million Americans are living with at least one...
Trial Library Raises $10 Million Series A to Expand Access to Clinical Trials as a Care Option
Co-led by SemperVirens Venture Capital and Next Ventures, with participation by Sanofi Ventures, Lux Capital, Civilization Ventures, How Women Invest...
Medical Care Technologies Inc. (OTC PINK:MDCE) Expands Development of Consumer-Grade AI Pre-Health Screening Tools Focused on Early Detection
MESA, ARIZONA / ACCESS Newswire / December 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the...
StimCell Energetics Inc. Announces Study into eBalance(R) Device’s Impact on Neuronal Mitochondrial Function
VANCOUVER, BC / ACCESS Newswire / December 2, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech...
Promino Resumes Trading and Achieves Record Sales Growth Through October 2025
Burlington, Ontario--(Newsfile Corp. - December 2, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or...
Hemostemix to Attend DFCon San Antonio and Closed its Private Placement
Calgary, Alberta--(Newsfile Corp. - December 2, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is proud to announce its...
St. Baldrick’s Launches Giving Tuesday Campaign to Raise $75,000 for Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - December 2, 2025) - This Giving Tuesday the St. Baldrick's Foundation, the largest charity funder...
BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
MILAN, Dec. 02, 2025 (GLOBE NEWSWIRE) -- BetaGlue® Therapeutics (“BetaGlue” or the “Company”) a pioneering Italian clinical-stage oncology company developing...
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a...
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
– Dr. Tagliaferri is a proven executive recognized for advancing innovative therapies across immunology, oncology and other serious diseases –...
Aeroflow Health Celebrates Giving Tuesday Through Donations to Western North Carolina Organizations
Aeroflow donates several thousand dollars across seven local organizations based in its home stateASHEVILLE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE)...
Lumina360 Platform to Streamline Complex Care for Skilled Nursing
Lumina Care's new EHR-integrated dashboard reduces complications and costs for clinicians and administrators NEW YORK CITY, NEW YORK / ACCESS...
Reema Health Tackles Medicaid Challenges with $19M Series B from LRVHealth and Optum Ventures
Engagement Model Blending Humans and Technology Drives 3X ROI to Medicaid MCOsMINNEAPOLIS, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Reema Health,...
Who Does the Best Tummy Tuck in Sarasota?
The Best Tummy Tuck in Sarasota is by Dr. Sessa SARASOTA, FLORIDA / ACCESS Newswire / December 2, 2025 /...
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Locally Recurrent Prostate Cancer
- FDA approval marks Alpha Tau’s fifth simultaneous active U.S. IDE as the Company expands Alpha DaRT’s reach into recurrent...
Strive Pharmacy Breaks Ground on New 350,000 Sq. Ft. Arizona Headquarters and Compounding Facility, Strengthening Its National Leadership in Patient-Focused Innovation
New Mesa campus deepens Strive's roots in Arizona, expands production capabilities, and accelerates job creation as the company surpasses 700,000...
Citizen Health Joins Forces with UCB to Accelerate Drug Development across Epilepsy and Rare Diseases
The multi-year partnership launches with focus on epilepsy, rare disease and AISAN FRANCISCO and ATLANTA, Dec. 02, 2025 (GLOBE NEWSWIRE)...
Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia®A novel non-antibiotic approach...
Orbus Therapeutics Announces Publication of Phase 3 STELLAR Clinical Study Results Showing Clinically Meaningful Improvements in Rare Brain Tumor in Journal of Clinical Oncology (JCO)
– Eflornithine and lomustine combination doubled progression free survival (PFS) and improved overall survival (OS) in patients with recurrent Grade...